Hyper CVAD MA治疗急性淋巴细胞白血病临床观察

　　【参考文献】

　　[1] kantarjian HM,O Brien S,Smith TL,et al.Result of treatment with hyper-CVAD, a dose-intensive regimen,in adult acute lymphocytic leukemia.J Clin Oncol,2000,18(3):547～561.

　　[2] kantarjian H,Thomas D,O Brien,et al.Long-term follow-up results of hyperfractionated cyclophosphamide,vincristine,doxorubincin,and dexamethasone(Hyper-CVAD), A does-intensive regimen,in adult acute lymphocytic leukemia.Cancer,2004,101(12):2　788～2 801.

　　[3] Hoelzer D.Prognosis factors in acute lymphoblastic leukemia.Leukemia,1992,6(suppl4):49　251.

　　[4] 沈 杨,沈志祥主编.急性淋巴细胞白血病研究进展.第1版.北京:人民卫生出版社, 2000:1～30.

　　[5] 张之南,沈 悌主编.血液病诊断及疗效标准.第3版.北京:科学出版社,2007:116～121.

　　[6] 颜灵芝,杨明珍,吴德沛.急性淋巴细胞白血病的诊断和治疗进展.国际输血及血液学杂志,2007,30(5):411～415.

　　[7] Murphy SB,Bowman WP,Abromowitch M,et al.Result of treatment of advanced-stage Burkitt S lymophoma and B cell(Sig+) acute lymphocytic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.J Clin Oncol,1986,4(12):1　732～1　739.

　　[8] Radich JP.Philadelphia chromosome-positive acute lymphocytic leukemia.Hematol Oncol Clin North Am,2001,15(1):21～36.
仁和医学论文网专业提供代写代发医学论文服务，并提供大量论文资料，如有业务需求请咨询网站客服人员！

上一页  [1] [2] [3]